A VLP for validation of the Plasmodium falciparum circumsporozoite protein junctional epitope for vaccine development
Abstract Malaria continues to be a pressing global health issue, causing nearly half a million deaths per year. An effective malaria vaccine could radically improve our ability to control and eliminate this pathogen. The most advanced malaria vaccine, RTS,S, confers only 30% protective efficacy unde...
Guardado en:
Autores principales: | Erwan Atcheson, Adrian V. S. Hill, Arturo Reyes-Sandoval |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8ced57f921af48a3b8a7e7217fdf7c7d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
An epitope-based malaria vaccine targeting the junctional region of circumsporozoite protein
por: Lucie Jelínková, et al.
Publicado: (2021) -
Assessment of genetic diversity of Plasmodium falciparum circumsporozoite protein in Sudan: the RTS,S leading malaria vaccine candidate
por: Nouh Saad Mohamed, et al.
Publicado: (2021) -
Epitope-coated polymer particles elicit neutralising antibodies against Plasmodium falciparum sporozoites
por: Benjamin J. Evert, et al.
Publicado: (2021) -
Genetic variation in the Plasmodium falciparum circumsporozoite protein in India and its relevance to RTS,S malaria vaccine.
por: Mohammad Zeeshan, et al.
Publicado: (2012) -
Identification of a neutralizing epitope within minor repeat region of Plasmodium falciparum CS protein
por: J. Mauricio Calvo-Calle, et al.
Publicado: (2021)